Stay updated on ProMIS Neurosciences Press Releases
Sign up to get notified when there's something new on the ProMIS Neurosciences Press Releases page.

Latest updates to the ProMIS Neurosciences Press Releases page
- CheckyesterdayChange DetectedA new line to view the PRECISE-AD Phase 1b Blinded Interim Data Analysis webinar replay was added, and the Second Quarter 2026 Earnings Conference Call listing was removed.SummaryDifference0.4%

- Check8 days agoChange DetectedA new item announcing ProMIS Neurosciences' participation in upcoming conferences and events in September has been added with the date Sep 1, 2026. The listing for BriefGlance.com coverage of 'ProMIS Unveils Precision Vaccines for ALS and Parkinson's Disease' dated Mar 19, 2026 has been removed.SummaryDifference2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a new press release entry titled 'ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights' with the date Aug 13, 2026. Removed the press release titled 'ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)' with the date Mar 18, 2026 from the listing.SummaryDifference2%

- Check37 days agoChange DetectedAdded an entry announcing the Second Quarter 2026 Earnings Conference Call. Included a notice that ProMIS will report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 (dated Aug 3, 2026).SummaryDifference2%

- Check44 days agoChange DetectedAdds two new press-release entries about PRECISE-AD Phase 1b data and a webinar replay (dated Jul 28 and Jul 27, 2026); removes older releases about private placement financing and trial enrollment.SummaryDifference9%

- Check58 days agoChange DetectedAdded a new press release entry dated Jul 14, 2026 announcing PMN310's first human evidence of amyloid-beta oligomer target engagement at AAIC 2026; removed the Dec 10, 2025 item about a peer-reviewed publication highlighting selective targeting of toxic oligomers and reduced ARIA risk.SummaryDifference2%

Stay in the know with updates to ProMIS Neurosciences Press Releases
Enter your email address, and we'll notify you when there's something new on the ProMIS Neurosciences Press Releases page.